Wall Street brokerages expect Tenet Healthcare Corp (NYSE:THC) to post earnings per share (EPS) of $0.10 for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have made estimates for Tenet Healthcare’s earnings. The lowest EPS estimate is ($0.01) and the highest is $0.20. Tenet Healthcare reported earnings per share of ($0.17) in the same quarter last year, which would suggest a positive year-over-year growth rate of 158.8%. The firm is expected to issue its next earnings report on Friday, October 26th.
On average, analysts expect that Tenet Healthcare will report full-year earnings of $1.70 per share for the current financial year, with EPS estimates ranging from $1.61 to $1.84. For the next year, analysts forecast that the company will post earnings of $1.97 per share, with EPS estimates ranging from $1.52 to $2.45. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that cover Tenet Healthcare.
Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Monday, August 6th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.24. Tenet Healthcare had a positive return on equity of 38.91% and a negative net margin of 2.51%. The firm had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.57 billion. During the same period in the prior year, the business earned ($0.17) EPS. The company’s revenue for the quarter was down 6.2% compared to the same quarter last year.
A number of research analysts have commented on THC shares. Mizuho reaffirmed a “buy” rating and set a $35.00 price target on shares of Tenet Healthcare in a research report on Wednesday, May 9th. Citigroup upped their price target on Tenet Healthcare from $27.00 to $37.00 and gave the stock a “buy” rating in a research note on Tuesday, May 8th. ValuEngine upgraded Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Zacks Investment Research raised Tenet Healthcare from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Monday, May 28th. Finally, Barclays assumed coverage on Tenet Healthcare in a report on Tuesday, August 14th. They set an “equal weight” rating and a $35.00 price target on the stock. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company. Tenet Healthcare currently has an average rating of “Hold” and a consensus target price of $30.24.
Shares of NYSE THC traded up $0.49 during midday trading on Thursday, reaching $33.20. The company had a trading volume of 1,590,200 shares, compared to its average volume of 2,092,356. Tenet Healthcare has a one year low of $12.25 and a one year high of $39.74. The company has a current ratio of 1.08, a quick ratio of 1.01 and a debt-to-equity ratio of 24.66. The firm has a market cap of $3.48 billion, a PE ratio of 40.52, a price-to-earnings-growth ratio of 1.54 and a beta of 1.05.
Large investors have recently bought and sold shares of the business. James Investment Research Inc. purchased a new stake in Tenet Healthcare in the second quarter valued at $2,520,000. GVO Asset Management Ltd purchased a new stake in Tenet Healthcare in the second quarter valued at $1,101,000. Prudential Financial Inc. boosted its holdings in Tenet Healthcare by 390.1% in the first quarter. Prudential Financial Inc. now owns 266,945 shares of the company’s stock valued at $6,473,000 after purchasing an additional 212,480 shares during the last quarter. Sei Investments Co. boosted its holdings in Tenet Healthcare by 9.0% in the second quarter. Sei Investments Co. now owns 506,380 shares of the company’s stock valued at $16,999,000 after purchasing an additional 41,761 shares during the last quarter. Finally, Swiss National Bank raised its position in shares of Tenet Healthcare by 4.3% in the first quarter. Swiss National Bank now owns 175,600 shares of the company’s stock worth $4,258,000 after acquiring an additional 7,300 shares during the period.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Story: Find a Trading Strategy That Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.